Download PDF
Go back to website
If you have problems to see the content please click here
Other users also viewed these articles
Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo wireless esophageal pH monitoring study
R. Schey, S.P. Alla, D. Midani, H.P. Parkman
10.1016/j.rgmxen.2017.07.002
Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor
A. López-Colombo, M.S. Pacio-Quiterio, L.Y. Jesús-Mejenes, J.E.G. Rodríguez-Aguilar, M. López-Guevara, A.J. Montiel-Jarquín, J.C. López-Alvarenga, E.R. Morales-Hernández, V.R. Ortiz-Juárez, L. Ávila-Jiménez
10.1016/j.rgmxen.2017.03.002
Proton pump inhibitor-responsive esophageal eosinophilia: A new entity in search of recognition?
D. García-Compeán, J.A. González-González, E.I. González-Moreno, E. Barrera-Villarreal, H.J. Maldonado-Garza
10.1016/j.rgmxen.2016.03.001